Altimmune Inc (ALT)
$12.93 0.64 (4.72%)
19:58 EST ALT Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 449.27M
PE Ratio -3.61
Volume (Avg. Vol.) 1.13M
Day's Range 12.71 - 13.91
52-Week Range 1.60 - 35.10
Dividend & Yield N/A (N/A)
ALT Stock Predictions, Articles, and Altimmune Inc News
- From InvestorPlace
- From the Web
Technology and biotech stocks brought in more winning picks than usual, thanks partly to the strong stock market. Here are some of my best calls.
Altimmune earnings from Tuesday evening have ALT stock higher despite the company reporting rough figures for second quarter of FY2020.
Altimmune (ALT) earnings for the biopharmaceutical company's fiscal year of 2019 have ALT stock taking a dive Friday after missing estimates.
There's no guarantee of a coronavirus cure, but Altimmune stock is worth owning on hopes of an effective vaccine.
Altimmune (ALT) news for Monday includes positive news about a vaccine to treat the coronavirus from China have ALT stock soaring higher.
Altimmune news concerning the results from a Phase 2 extension study of the company's NasoVAX has ALT stock heading higher today.
Altimmune stock was falling hard Monday on news that the company is selling additional stock to investors in a new offering.
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader